
Moka Therapeutics is an AI-powered ethnobotanic drug discovery platform that aims to unlock the potential of nature for therapeutic applications. The company uses its proprietary platform to identify new ethnobotanical molecules and their mechanisms of action, addressing the challenge of identifying therapeutic molecules and their synergies within ethnobotanics. Moka Therapeutics plans to initially offer its formulations and services to the Food & Agriculture and Cosmetics industries to build credibility before focusing on the pharmaceutical industry for natural drug discovery. Their business model involves SaaS offerings and co-development/licensing contracts, with a focus on creating value through Intellectual Property Assets.

Moka Therapeutics is an AI-powered ethnobotanic drug discovery platform that aims to unlock the potential of nature for therapeutic applications. The company uses its proprietary platform to identify new ethnobotanical molecules and their mechanisms of action, addressing the challenge of identifying therapeutic molecules and their synergies within ethnobotanics. Moka Therapeutics plans to initially offer its formulations and services to the Food & Agriculture and Cosmetics industries to build credibility before focusing on the pharmaceutical industry for natural drug discovery. Their business model involves SaaS offerings and co-development/licensing contracts, with a focus on creating value through Intellectual Property Assets.